MedPath

TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL Red Cell Preservative

TERUFLEX® BLOOD BAG SYSTEM CPD/OPTISOL® SOLUTION BLOOD BAG SYSTEM

Approved
Approval ID

06da7814-b638-424e-bb37-66be346040d2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 11, 2019

Manufacturers
FDA

Terumo Corporation

DUNS: 690543319

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53877-005
Application NumberBN880217
Product Classification
M
Marketing Category
C73594
G
Generic Name
Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 11, 2019
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL Red Cell Preservative - FDA Drug Approval Details